ETAP-Lab provides preclinical models and services in the fields of Dermatology, Stroke and Neurodegenerative Diseases.

The company has strong expertise in the field of Dermatology research and offers a large portfolio of original in vivo rodent models such as chronic skin inflammation, ischemic ulceration, psoriasis, hyperkeratosis, wound healing, atopic dermatitis, actinic keratosis, skin cancer…

ETAP-Lab is also leader in the field of preclinical stroke research with a unique model portfolio consisting of innovative and translational models proposed under the brand Strok@lliance.

With more than 2 decades of experience, ETAP-Lab has become a best-in-class service provider for top tier Pharma, Medical device and Agri-food companies and obtained ISO9001:v2015 certification for all its preclinical services.

ETAP-Lab is listening to the needs of their clients to offer the most suited solution for products evaluation. Thus, its team is able to develop and customize relevant animal models with high translational value that fit to specific goals, from the proof-of-concept to the early development. 

Feel free to contact us!


Biotechnology

Health Care

Life Sciences

Pharmaceutical

Therapeutics

ETAP-Lab - Preclinical Efficacy CRO

ETAP-Lab - Preclinical Efficacy CRO's headquarters in Vandoeuvre-lès-Nancy, France

Nicolas Violle

Jean-François Bisson

Pascale Rozan

Anaïs Gavoille

ETAP-Lab - Preclinical Efficacy CRO

Org chart

Teams

Offices

Similar companies